Videos
Press Releases

17 Mar 2022
MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression

29 Jun 2021
PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients

4 Jun 2021
PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer

20 Apr 2021
PRESS RELEASE: HSH Prince Albert II cedes Honorary Presidency of the EORTC Research Fund to HRH Princess Dina Mired
Latest Newsletter
News

5 May 2025
Defining the role of pragmatic clinical trials in clinical cancer research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer (EORTC)

2 May 2025
Important new results from EORTC presented at ESTRO Congress 2025

1 Apr 2025
Brain Tumour Group,Breast Cancer Group,Cutaneous Lymphoma Tumours Group,Diagnostic and Therapeutic Imaging,Endocrine Tumours Group,Gastrointestinal Tract Cancer Group,Genito-Urinary Cancers Group,Gynecological Cancer Group,Head and Neck Cancer Group,Leukemia Group,Lung Cancer Group,Lymphoma Group,Melanoma Group,News,Older Adults Council,Pathobiology Group,Pharmacology & Molecular Mechanisms Group,Quality of Life Group
New study confirms link between cancer patients’ quality of life and survival

17 Mar 2025
New Treatment for Recurrent Meningioma: LUMEN-1 Clinical Trial

6 Feb 2025
SISAQOL-IMI consortium launches final recommendations

4 Feb 2025
World Cancer Day 2025: EORTC’s commitment to older patients

11 Dec 2024
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

21 Nov 2024
Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research

5 Nov 2024
EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients


